2023 Q4 Form 10-Q Financial Statement
#000165495423014575 Filed on November 20, 2023
Income Statement
Concept | 2023 Q4 | 2023 Q3 | 2022 Q3 |
---|
Balance Sheet
Concept | 2023 Q4 | 2023 Q3 | 2022 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $62.00K | $401.0K | |
YoY Change | -84.54% | -59.98% | |
Cash & Equivalents | €62.00K | €401.0K | |
Short-Term Investments | |||
Other Short-Term Assets | $24.00K | $138.0K | |
YoY Change | -82.61% | 8.66% | |
Inventory | |||
Prepaid Expenses | €24.00K | €138.0K | |
Receivables | €13.00K | €58.00K | |
Other Receivables | $0.00 | $0.00 | |
Total Short-Term Assets | €99.00K | €597.0K | |
YoY Change | -83.42% | -48.58% | |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | €1.000K | €30.00K | |
YoY Change | -96.67% | -31.82% | |
Goodwill | €0.00 | €6.671M | |
YoY Change | -100.0% | 0.0% | |
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $0.00 | $10.00K | |
YoY Change | -100.0% | 0.0% | |
Total Long-Term Assets | €1.000K | €6.870M | |
YoY Change | -99.99% | 1.39% | |
TOTAL ASSETS | |||
Total Short-Term Assets | €99.00K | €597.0K | |
Total Long-Term Assets | €1.000K | €6.870M | |
Total Assets | €100.0K | €7.467M | |
YoY Change | -98.66% | -5.92% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | €559.0K | €48.00K | |
YoY Change | 1064.58% | -31.43% | |
Accrued Expenses | $0.00 | $106.0K | |
YoY Change | -100.0% | 96.3% | |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $74.97M | $71.07M | |
YoY Change | 5.49% | 6.85% | |
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | €75.53M | €71.22M | |
YoY Change | 6.04% | 6.86% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | €145.0K | €176.0K | |
YoY Change | -17.61% | 12.82% | |
Other Long-Term Liabilities | $0.00 | $57.00K | |
YoY Change | -100.0% | ||
Total Long-Term Liabilities | €145.0K | €233.0K | |
YoY Change | -37.77% | 49.36% | |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | €75.53M | €71.22M | |
Total Long-Term Liabilities | €145.0K | €233.0K | |
Total Liabilities | €75.67M | €71.45M | |
YoY Change | 5.9% | 6.96% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -€113.2M | -€101.6M | |
YoY Change | 11.38% | -205.31% | |
Common Stock | €2.530M | €2.530M | |
YoY Change | 0.0% | 0.0% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -€75.57M | -€63.99M | |
YoY Change | |||
Total Liabilities & Shareholders Equity | €100.0K | €7.467M | |
YoY Change | -98.66% | -5.92% |
Cashflow Statement
Concept | 2023 Q4 | 2023 Q3 | 2022 Q3 |
---|
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
7321000 | eur |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
313000 | eur |
CY2023Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
13000 | eur |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
62000 | eur |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
106000 | eur |
CY2023Q3 | us-gaap |
Assets Current
AssetsCurrent
|
99000 | eur |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
481000 | eur |
CY2023Q3 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
0 | eur |
CY2022Q4 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
10000 | eur |
CY2023Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1000 | eur |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
26000 | eur |
CY2023Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
0 | eur |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
133000 | eur |
CY2023Q3 | us-gaap |
Goodwill
Goodwill
|
0 | eur |
CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
6671000 | eur |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
213000 | eur |
CY2023Q3 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
0 | eur |
CY2022Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
7000 | eur |
CY2023Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
0 | eur |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
106000 | eur |
CY2023Q3 | mymx |
Non Convertible Notes Payable And Related Accrued Interest To Related Parties
NonConvertibleNotesPayableAndRelatedAccruedInterestToRelatedParties
|
11755000 | eur |
CY2022Q4 | mymx |
Non Convertible Notes Payable And Related Accrued Interest To Related Parties
NonConvertibleNotesPayableAndRelatedAccruedInterestToRelatedParties
|
10461000 | eur |
CY2023Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
75525000 | eur |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
72030000 | eur |
CY2023Q3 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
145000 | eur |
CY2022Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
156000 | eur |
CY2022Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
187000 | eur |
CY2023Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
2530000 | eur |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-102555000 | eur |
CY2023Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
672000 | eur |
CY2022Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
686000 | eur |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-75570000 | eur |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-64896000 | eur |
CY2018Q2 | us-gaap |
Investment Interest Rate
InvestmentInterestRate
|
0.025 | pure |
CY2019Q2 | us-gaap |
Investment Interest Rate
InvestmentInterestRate
|
0.025 | pure |
CY2019Q4 | us-gaap |
Investment Interest Rate
InvestmentInterestRate
|
0.025 | pure |
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000927761 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | ||
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1200000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
303757622 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
303757622 | shares |
CY2023Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
303757622 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q3 | us-gaap |
Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
|
793630391 | shares |
mymx |
Basic Weighted And Diluted Number Of Share
BasicWeightedAndDilutedNumberOfShare
|
303757622 | shares | |
CY2023Q3 | mymx |
Basic Weighted And Diluted Number Of Share
BasicWeightedAndDilutedNumberOfShare
|
303757622 | shares |
CY2023Q3 | us-gaap |
Interest Paid
InterestPaid
|
500.0 | eur |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-09-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
000-25132 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
MYMETICS CORPORATION | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
25-1741849 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
c/o Mymetics SA | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Route de la Corniche 4 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Epalinges | ||
dei |
Entity Address Country
EntityAddressCountry
|
CH | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
1066 | ||
dei |
City Area Code
CityAreaCode
|
011 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
41 21 566 57 72 | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock, Par Value $0.01 per share | ||
dei |
Trading Symbol
TradingSymbol
|
MYMX | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2023Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
303757622 | shares |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
62000 | eur |
CY2023Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
24000 | eur |
CY2023Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
498000 | eur |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
475000 | eur |
CY2023Q3 | us-gaap |
Assets
Assets
|
100000 | eur |
CY2022Q4 | us-gaap |
Assets
Assets
|
7321000 | eur |
CY2023Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
559000 | eur |
CY2023Q3 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
63211000 | eur |
CY2022Q4 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
61243000 | eur |
CY2023Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
0 | eur |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
31000 | eur |
CY2023Q3 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
145000 | eur |
CY2023Q3 | us-gaap |
Liabilities
Liabilities
|
75670000 | eur |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
72217000 | eur |
CY2023Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
0 | eur |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
0 | eur |
CY2023Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2023Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1200000000 | shares |
CY2023Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
303757622 | shares |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
2530000 | eur |
CY2023Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2023Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2023Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | eur |
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | eur |
CY2023Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
34443000 | eur |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
34443000 | eur |
CY2023Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-113215000 | eur |
CY2023Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
100000 | eur |
CY2023Q3 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
0 | eur |
CY2022Q3 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
0 | eur |
us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
3000 | eur | |
us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
0 | eur | |
CY2023Q3 | mymx |
Other Income Grants
OtherIncomeGrants
|
34000 | eur |
CY2022Q3 | mymx |
Other Income Grants
OtherIncomeGrants
|
130000 | eur |
mymx |
Other Income Grants
OtherIncomeGrants
|
411000 | eur | |
mymx |
Other Income Grants
OtherIncomeGrants
|
909000 | eur | |
CY2023Q3 | us-gaap |
Revenues
Revenues
|
34000 | eur |
CY2022Q3 | us-gaap |
Revenues
Revenues
|
130000 | eur |
us-gaap |
Revenues
Revenues
|
414000 | eur | |
us-gaap |
Revenues
Revenues
|
909000 | eur | |
CY2023Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
60000 | eur |
CY2022Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
209000 | eur |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
854000 | eur | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1191000 | eur | |
CY2023Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
355000 | eur |
CY2022Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
320000 | eur |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1515000 | eur | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
979000 | eur | |
CY2023Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
415000 | eur |
CY2022Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
529000 | eur |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
2369000 | eur | |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
2170000 | eur | |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-381000 | eur |
CY2022Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-399000 | eur |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1955000 | eur | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1261000 | eur | |
CY2023Q3 | us-gaap |
Interest Expense
InterestExpense
|
710000 | eur |
CY2022Q3 | us-gaap |
Interest Expense
InterestExpense
|
703000 | eur |
us-gaap |
Interest Expense
InterestExpense
|
2118000 | eur | |
us-gaap |
Interest Expense
InterestExpense
|
2096000 | eur | |
CY2023Q3 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | eur |
CY2022Q3 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | eur |
us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
6671000 | eur | |
us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | eur | |
CY2023Q3 | us-gaap |
Other General Expense
OtherGeneralExpense
|
23000 | eur |
CY2022Q3 | us-gaap |
Other General Expense
OtherGeneralExpense
|
243000 | eur |
us-gaap |
Other General Expense
OtherGeneralExpense
|
84000 | eur | |
us-gaap |
Other General Expense
OtherGeneralExpense
|
541000 | eur | |
CY2023Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1114000 | eur |
CY2022Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1345000 | eur |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-10660000 | eur | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-3898000 | eur | |
CY2023Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | eur |
CY2022Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | eur |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | eur | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | eur | |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1114000 | eur |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1345000 | eur |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-10660000 | eur | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3898000 | eur | |
CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
-5000 | eur |
CY2022Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
-7000 | eur |
us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
-14000 | eur | |
us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
-2000 | eur | |
CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
-1119000 | eur |
CY2022Q3 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
-1352000 | eur |
us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
-10674000 | eur | |
us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
-3900000 | eur | |
CY2023Q3 | mymx |
Earnings Per Share Basic And Dilutive
EarningsPerShareBasicAndDilutive
|
-0.00 | |
CY2022Q3 | mymx |
Earnings Per Share Basic And Dilutive
EarningsPerShareBasicAndDilutive
|
-0.00 | |
mymx |
Earnings Per Share Basic And Dilutive
EarningsPerShareBasicAndDilutive
|
-0.04 | ||
mymx |
Earnings Per Share Basic And Dilutive
EarningsPerShareBasicAndDilutive
|
-0.01 | ||
CY2023Q3 | mymx |
Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
|
303757622000 | shares |
CY2022Q3 | mymx |
Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
|
303757622000 | shares |
mymx |
Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
|
303757622000 | shares | |
mymx |
Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
|
303757622000 | shares | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-60086000 | eur |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1211000 | eur |
CY2022Q1 | mymx |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustment
|
7000 | eur |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-61290000 | eur |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1342000 | eur |
CY2022Q2 | mymx |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustment
|
-2000 | eur |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-62634000 | eur |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1345000 | eur |
CY2022Q3 | mymx |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustment
|
-7000 | eur |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-63986000 | eur |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-64896000 | eur |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1861000 | eur |
CY2023Q1 | mymx |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustment
|
0 | eur |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-66757000 | eur |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7685000 | eur |
CY2023Q2 | mymx |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustment
|
-9000 | eur |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-74451000 | eur |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1114000 | eur |
CY2023Q3 | mymx |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustment
|
-5000 | eur |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-75570000 | eur |
us-gaap |
Profit Loss
ProfitLoss
|
10660000 | eur | |
us-gaap |
Profit Loss
ProfitLoss
|
3898000 | eur | |
us-gaap |
Depreciation
Depreciation
|
9000 | eur | |
us-gaap |
Depreciation
Depreciation
|
11000 | eur | |
us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
6671000 | eur | |
us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | eur | |
us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
75000 | eur | |
us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
0 | eur | |
us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-49000 | eur | |
us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
43000 | eur | |
us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
1968000 | eur | |
us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
2436000 | eur | |
mymx |
Increase Decrease In Other Interest Payable Net
IncreaseDecreaseInOtherInterestPayableNet
|
194000 | eur | |
mymx |
Increase Decrease In Other Interest Payable Net
IncreaseDecreaseInOtherInterestPayableNet
|
161000 | eur | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
346000 | eur | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1000 | eur | |
us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
-81000 | eur | |
us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
34000 | eur | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1417000 | eur | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1366000 | eur | |
us-gaap |
Proceeds From Sale Of Flight Equipment
ProceedsFromSaleOfFlightEquipment
|
94000 | eur | |
us-gaap |
Proceeds From Sale Of Flight Equipment
ProceedsFromSaleOfFlightEquipment
|
0 | eur | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | eur | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2000 | eur | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
94000 | eur | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2000 | eur | |
us-gaap |
Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
|
14000 | eur | |
us-gaap |
Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
|
0 | eur | |
mymx |
Proceeds From Issuance Of Non Convertible Stock
ProceedsFromIssuanceOfNonConvertibleStock
|
1100000 | eur | |
mymx |
Proceeds From Issuance Of Non Convertible Stock
ProceedsFromIssuanceOfNonConvertibleStock
|
1200000 | eur | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1086000 | eur | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1200000 | eur | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-14000 | eur | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-2000 | eur | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-251000 | eur | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-170000 | eur | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
313000 | eur |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
571000 | eur |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
62000 | eur |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
401000 | eur |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | eur | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | eur | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | eur | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | eur | |
CY2023Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-113215000 | eur |
CY2023Q3 | mymx |
Exceed Current Liabilities
ExceedCurrentLiabilities
|
75426000 | eur |
mymx |
Description Of Overall Budget
DescriptionOfOverallBudget
|
The overall budget related to the project is US$8,850 with US$8,761 approved for the period of (May 2019 to April 2024). This includes the funds approved for the period of May 2023 to April 2024 of US$1’630 | ||
mymx |
Description Of Grant Allocated
DescriptionOfGrantAllocated
|
The amounts mentioned in the following statements are purely related to the Company and not to the other partners in the project: The overall portion of the grant allocated to the Company is US$4,052 approved for the period of May 2019 to April 2024. This includes the funds approved for the period of May 2023 to April 2024 of US$97. In March 2023, an amendment to the contract was signed to reduce the allocated funds from ULL to the Company from US$1,328 to US$ 815, as more funds were allocated to the animal studies at ULL | ||
CY2023Q3 | mymx |
Sub Award Grant Revenue Us Dollar
SubAwardGrantRevenueUSDollar
|
36000 | usd |
CY2023Q3 | mymx |
Sub Award Grant Revenue Euro
SubAwardGrantRevenueEuro
|
30000 | eur |
mymx |
Sub Award Grant Revenue Us Dollar
SubAwardGrantRevenueUSDollar
|
440000 | usd | |
mymx |
Sub Award Grant Revenue Euro
SubAwardGrantRevenueEuro
|
406000 | eur | |
mymx |
Basic Weighted And Diluted Number Of Share
BasicWeightedAndDilutedNumberOfShare
|
303757622 | shares | |
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
|
830150223 | shares |
CY2023Q3 | mymx |
Weighted Average Number Of Shares Contingently Convertible Loans
WeightedAverageNumberOfSharesContingentlyConvertibleLoans
|
804400223 | shares |
CY2022Q3 | mymx |
Basic Weighted And Diluted Number Of Share
BasicWeightedAndDilutedNumberOfShare
|
303757622 | shares |
us-gaap |
Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
|
793630391 | shares | |
CY2022Q3 | mymx |
Weighted Average Number Of Shares Contingently Convertible Loans
WeightedAverageNumberOfSharesContingentlyConvertibleLoans
|
767880391 | shares |
us-gaap |
Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
|
25750000000 | shares | |
CY2023Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> | ||
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company derived 99% and 100% of grant revenue for the nine-month periods ended September 30, 2023 and 2022, respectively, from one grantor, respectively. For the period ended December 31, 2022, the Company derived 100% of grant revenue from one partner.</p> | ||
CY2023Q3 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
74483000 | eur |
CY2023Q3 | us-gaap |
Debt Instrument Fair Value
DebtInstrumentFairValue
|
74966000 | eur |
CY2023Q3 | us-gaap |
Debt Default Shortterm Debt Amount
DebtDefaultShorttermDebtAmount
|
38676000 | eur |
us-gaap |
Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
|
36290000 | eur | |
CY2023Q3 | us-gaap |
Debt Instrument Fair Value
DebtInstrumentFairValue
|
74966000 | eur |
mymx |
Description Of Conversion Price
DescriptionOfConversionPrice
|
(i) reducing by 10% the price per share of the Company’s common stock paid by the investors in connection with an investment in the Company of not less than US$20,000, or (ii) at the fixed conversion price using a fixed exchange rate which are noted in the table above | ||
CY2017Q1 | us-gaap |
Investment Interest Rate
InvestmentInterestRate
|
0.025 | pure |
CY2017Q1 | us-gaap |
Debt Instrument Description
DebtInstrumentDescription
|
The first 50% of the promissory Notes of €920 and €230, respectively, were provided immediately. The second 50% of the promissory notes of €920 and €230, respectively, were provided on October 18, 2017, with a 2.5% interest per annum and a maturity date of October 18, 2018 | |
CY2018Q2 | us-gaap |
Debt Instrument Description
DebtInstrumentDescription
|
The first tranche of the promissory Notes of €640 and €160, respectively, were provided immediately. The second tranche of the promissory notes of €640 and €160, respectively, were provided on November 10, 2018, with a 2.5% interest per annum | |
CY2019Q2 | mymx |
Promissory Notes
PromissoryNotes
|
600000 | eur |
CY2019Q2 | us-gaap |
Debt Instrument Description
DebtInstrumentDescription
|
The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes | |
CY2019Q4 | mymx |
Promissory Notes
PromissoryNotes
|
600000 | eur |
CY2019Q4 | us-gaap |
Debt Instrument Description
DebtInstrumentDescription
|
The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) June 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes | |
CY2020Q2 | mymx |
Promissory Notes
PromissoryNotes
|
1100000 | eur |
CY2020Q2 | us-gaap |
Investment Interest Rate
InvestmentInterestRate
|
0.025 | pure |
CY2020Q2 | us-gaap |
Debt Instrument Description
DebtInstrumentDescription
|
The promissory Notes of €880 and €220, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) September 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes | |
CY2020Q4 | mymx |
Promissory Notes
PromissoryNotes
|
850000 | eur |
CY2020Q4 | us-gaap |
Investment Interest Rate
InvestmentInterestRate
|
0.025 | pure |
CY2020Q4 | us-gaap |
Debt Instrument Description
DebtInstrumentDescription
|
The promissory Notes of €680 and €170, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) March 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes | |
CY2021Q3 | mymx |
Promissory Notes
PromissoryNotes
|
1200000 | eur |
CY2021Q3 | us-gaap |
Investment Interest Rate
InvestmentInterestRate
|
0.025 | pure |
CY2021Q3 | us-gaap |
Debt Instrument Description
DebtInstrumentDescription
|
The promissory Notes of €960 and €240, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes | |
CY2022Q2 | mymx |
Promissory Notes
PromissoryNotes
|
960000 | eur |
CY2022Q2 | us-gaap |
Investment Interest Rate
InvestmentInterestRate
|
0.025 | pure |
CY2022Q3 | mymx |
Promissory Notes
PromissoryNotes
|
600000 | eur |
CY2022Q3 | us-gaap |
Investment Interest Rate
InvestmentInterestRate
|
0.025 | pure |
CY2022Q3 | us-gaap |
Debt Instrument Description
DebtInstrumentDescription
|
The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2022, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes | |
CY2022Q4 | mymx |
Promissory Notes
PromissoryNotes
|
250000 | eur |
CY2022Q4 | us-gaap |
Investment Interest Rate
InvestmentInterestRate
|
0.025 | pure |
CY2022Q4 | us-gaap |
Debt Instrument Description
DebtInstrumentDescription
|
The promissory Notes of €200 and €50, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) March 31, 2023, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes | |
CY2023Q1 | mymx |
Promissory Notes
PromissoryNotes
|
500000 | eur |
CY2023Q1 | us-gaap |
Investment Interest Rate
InvestmentInterestRate
|
0.025 | pure |
CY2023Q1 | us-gaap |
Debt Instrument Description
DebtInstrumentDescription
|
The promissory Notes of €400 and €100, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) June 30, 2023, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes | |
CY2023Q2 | mymx |
Promissory Notes
PromissoryNotes
|
600000 | eur |
CY2023Q2 | us-gaap |
Investment Interest Rate
InvestmentInterestRate
|
0.025 | pure |
CY2023Q2 | us-gaap |
Debt Instrument Description
DebtInstrumentDescription
|
The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) September 30, 2023, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes | |
CY2020Q2 | mymx |
Received From Federal Credit Line
ReceivedFromFederalCreditLine
|
168000 | eur |
CY2023Q3 | us-gaap |
Investment Interest Rate
InvestmentInterestRate
|
0.015 | pure |
us-gaap |
Interest Paid
InterestPaid
|
1000 | eur | |
us-gaap |
Servicing Asset At Amortized Value Risk Characteristics Description
ServicingAssetAtAmortizedValueRiskCharacteristicsDescription
|
A first amortization installment of Chf 14 (€14) was paid on October 3, 2022. A second amortization installment of Chf 14 (€14) was paid on April 3, 2023. The next amortization of €14 was incurred on September 30, 2023, but is paid on October 2, 2023. The entire loan should be fully amortized and repaid by September 30, 2027 | ||
CY2023Q4 | mymx |
Promissory Notes
PromissoryNotes
|
600000 | eur |